Pharmacology, Toxicology and Pharmaceutical Science
Levodopa-Induced Dyskinesia
89%
Glutamic Acid
62%
Positive Allosteric Modulator
60%
Parkinson's Disease
56%
Glutamate Receptor
50%
Callitrichinae
50%
Metabotropic Receptor 4
50%
Dyskinesia
50%
Oxidopamine
25%
Metabotropic Receptor 5
20%
Allosteric Modulator
20%
DOPA
18%
Clinical Trial
16%
Side Effect
16%
Amantadine
12%
Callithrix jacchus
12%
Replacement Therapy
10%
Preclinical Study
10%
N Methyl Dextro Aspartic Acid
10%
N Methyl Dextro Aspartic Acid Receptor
10%
Dopamine Receptor Stimulating Agent
10%
Foliglurax
6%
Carboxamide
6%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
6%
Cyclohexane
6%
Neuroscience
L-DOPA
100%
Dyskinesia
89%
Striatum
50%
Neuroscience
50%
Parkinson's Disease
10%
Soma
10%
Magnetic Resonance Imaging
10%
Oxidopamine
10%
Magnetic Resonance Imaging
10%
Carisoprodol
10%
Microglia
10%
Midbrain
5%
Medial Forebrain Bundle
5%
Staining Technique
5%
Structural Magnetic Resonance Imaging
5%
Frontal Lobe
5%
Voxel-Based Morphometry
5%
positron emission tomographic scan
5%
Functional Magnetic Resonance Imaging
5%
Cell Membrane Potential
5%
Astrocyte
5%
